Since 2022, we have been collaborating with the CMF (Center for Molecular Fingerprinting), a research institution dedicated to developing next-generation molecular diagnostics.
🔬 CMF’s vision is to capture the tiniest molecular changes in blood plasma using cutting-edge ultrashort-pulsed laser technology. With this pioneering approach, infrared molecular fingerprinting could become a cornerstone of future diagnostics and population health monitoring.
🌍 Led by Nobel Laureate Prof. Dr. Ferenc Krausz, CMF brings together an international, interdisciplinary team of medical experts, biologists, physicists, and data scientists, all working towards shaping the future of healthcare.
🤝 For BiTrial, this collaboration is more than a partnership, it places us at the forefront of clinical research, allowing us to contribute to key innovations that will define tomorrow’s medicine.
Learn more about CMF’s research on the institute’s website!
For more information and research contact us!